Back to search
Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related Disorders
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related Disorders trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related Disorders trials you may qualify forThe influence of pregnancy on the course of multiple sclerosis (MS) has long been a controversial topic. After the publication of the first large prospective st…
Anti-myelin oligodendrocyte glycoprotein-IgG-associated disorders (MOGAD) is a rare inflammatory autoimmune disease. In addition, since the international MOGAD…
This study is being conducted to investigate risk factors for disability progression in Multiple Sclerosis and related disorders (MSRD). The primary goal is to…